{"id":3627,"date":"2026-07-17T18:10:24","date_gmt":"2026-07-17T18:10:24","guid":{"rendered":"https:\/\/indiamedicine.org\/?p=3627"},"modified":"2026-07-17T18:10:24","modified_gmt":"2026-07-17T18:10:24","slug":"indian-generic-medicine-quality-testing-lab-standards-guide","status":"publish","type":"post","link":"https:\/\/indiamedicine.org\/?p=3627","title":{"rendered":"How Indian Generic Medicines Are Quality Tested: Lab Standards and Buyer&#8217;s Guide"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">One of the most common questions international buyers ask about Indian generic medicines is: <em>&#8220;How do I know the quality is real?&#8221;<\/em> The answer lies in the rigorous, multi-stage laboratory testing that every batch of medicine undergoes before it reaches the market. Understanding this testing framework can help buyers make informed decisions and evaluate suppliers with confidence.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">India is the <strong>world&#8217;s largest supplier of generic medicines by volume<\/strong>, accounting for approximately <strong>20% of global generic drug exports<\/strong> (Pharmexcil, 2025\u201326 data). This scale is supported by a comprehensive quality testing infrastructure that includes over <strong>1,400 NABL-accredited pharmaceutical testing laboratories<\/strong> and CDSCO-approved government testing facilities across the country.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f504; The Quality Testing Journey: From Raw Material to Finished Product<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Every batch of generic medicine in India passes through <strong>four distinct testing stages<\/strong> before it is released for sale:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Stage 1 \u2014 Raw Material (API) Testing:<\/strong> Every incoming batch of Active Pharmaceutical Ingredient (API) is tested for identity, purity, potency, and impurities before manufacturing begins. Rejected APIs never enter production.<\/li>\n<li><strong>Stage 2 \u2014 In-Process Quality Control (IPQC):<\/strong> During manufacturing, samples are taken at critical steps \u2014 blending, granulation, compression, coating \u2014 to ensure the product meets specifications at every stage.<\/li>\n<li><strong>Stage 3 \u2014 Finished Product Testing:<\/strong> The completed batch undergoes full pharmacopoeial testing: assay, dissolution, uniformity of content, impurity profiling, and microbial limits.<\/li>\n<li><strong>Stage 4 \u2014 Batch Release and Stability Testing:<\/strong> Only batches that pass all tests receive a Certificate of Analysis (CoA). Retained samples undergo real-time and accelerated stability studies to confirm shelf life.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This four-stage system is mandated under <strong>Schedule M of India&#8217;s Drugs and Cosmetics Rules<\/strong>, which codifies WHO-GMP standards into Indian law. The CDSCO enforces compliance through regular inspections and audits (<a href=\"https:\/\/cdsco.gov.in\" target=\"_blank\" rel=\"noopener\">cdsco.gov.in<\/a>).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f9ea; Key Quality Tests Every Batch Must Pass<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Indian manufacturers test each batch against the specifications of the relevant pharmacopoeia \u2014 typically the <strong>Indian Pharmacopoeia (IP)<\/strong>, <strong>British Pharmacopoeia (BP)<\/strong>, or <strong>United States Pharmacopeia (USP)<\/strong>. Here are the most important tests:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Assay (Potency Test):<\/strong> Measures the concentration of the active ingredient. A 500 mg paracetamol tablet must contain between 95.0% and 105.0% of the labelled amount (IP specification).<\/li>\n<li><strong>Dissolution Test:<\/strong> Determines how quickly the drug releases its active ingredient in simulated digestive fluids. This is the single most important test for predicting how the medicine will perform in the body.<\/li>\n<li><strong>Uniformity of Content\/Dosage Units:<\/strong> Ensures each tablet or capsule in a batch contains the same amount of active ingredient \u2014 critical for drugs with narrow therapeutic windows.<\/li>\n<li><strong>Related Substances \/ Impurity Profiling:<\/strong> Detects degradation products, process impurities, and residual solvents. Limits are set by ICH Q3 guidelines.<\/li>\n<li><strong>Disintegration Test:<\/strong> Confirms that tablets break apart within a specified time (typically 15-30 minutes for uncoated tablets).<\/li>\n<li><strong>Microbial Limits Testing:<\/strong> Checks for bacteria, yeast, mould, and specified pathogens (E. coli, Salmonella, S. aureus, Pseudomonas aeruginosa).<\/li>\n<li><strong>Sterility Testing (for injectables):<\/strong> Parenteral products must pass sterility tests per IP\/USP\/EP methods.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">According to the <strong>Indian Pharmacopoeia Commission<\/strong>, manufacturers are required to retain batch samples for <strong>at least one year beyond the expiry date<\/strong> to enable re-testing if quality concerns arise.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f52c; Active Pharmaceutical Ingredient (API) Testing<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The quality of the finished medicine depends directly on the quality of the API. India is a leading producer of APIs, supplying approximately <strong>57% of the world&#8217;s API demand<\/strong> (excluding China&#8217;s share). API testing includes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Identification<\/strong> \u2014 FTIR, HPLC retention time, or melting point confirmation<\/li>\n<li><strong>Assay<\/strong> \u2014 Purity determination by HPLC or UV spectrophotometry (typically 98.0%-102.0%)<\/li>\n<li><strong>Heavy Metals<\/strong> \u2014 Limits for lead, arsenic, mercury, cadmium, etc. (ICH Q3D)<\/li>\n<li><strong>Residual Solvents<\/strong> \u2014 GC testing per ICH Q3C classifications<\/li>\n<li><strong>Polymorph Purity<\/strong> \u2014 X-ray diffraction (XRD) to confirm the correct crystalline form<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Buyers should request the API&#8217;s <strong>Drug Master File (DMF)<\/strong> reference and confirm that the API supplier itself is WHO-GMP or EU-GMP certified. Reputable Indian manufacturers source APIs only from approved vendors who supply a Certificate of Analysis with every batch.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x23f1; Dissolution Testing: The Bioavailability Predictor<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Dissolution testing is arguably the <strong>most critical quality control test<\/strong> for solid oral dosage forms (tablets and capsules). It measures how much of the active ingredient is released into solution over time under controlled conditions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The test uses <strong>USP Apparatus 1 (basket)<\/strong> or <strong>USP Apparatus 2 (paddle)<\/strong> at 37\u00b0C in specified dissolution media (pH 1.2, 4.5, or 6.8 buffer solutions simulating digestive tract conditions). The typical specification is <strong>Q = 80%<\/strong> \u2014 meaning at least 80% of the labelled active ingredient must be dissolved within a specified time (usually 30\u201345 minutes).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For generic medicines, dissolution profiles are compared against the <strong>innovator (brand-name) product<\/strong> in bioequivalence studies (f2 similarity factor \u2265 50). This ensures the generic medicine releases the drug at the same rate and extent as the original. CDSCO mandates comparative dissolution data for all generic drug approvals in India (<a href=\"https:\/\/cdsco.gov.in\" target=\"_blank\" rel=\"noopener\">CDSCO guidance document<\/a>).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f4c4; Understanding the Certificate of Analysis (CoA)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The <strong>Certificate of Analysis (CoA)<\/strong> is the single most important document a buyer can request from their supplier. A complete CoA should contain:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Product name, batch number, and manufacturing date<\/strong><\/li>\n<li><strong>Expiry date and batch size<\/strong><\/li>\n<li><strong>Reference pharmacopoeia<\/strong> (IP, USP, BP, or EP)<\/li>\n<li><strong>List of tests performed<\/strong> with specifications and actual results<\/li>\n<li><strong>Date of testing and analyst signature<\/strong><\/li>\n<li><strong>QA\/QC manager authorisation<\/strong> with stamp<\/li>\n<li><strong>NABL accreditation number<\/strong> of the testing laboratory<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">A CoA from a NABL-accredited lab carries significant weight. The National Accreditation Board for Testing and Calibration Laboratories (NABL) is India&#8217;s equivalent of ISO\/IEC 17025 accreditation and is recognised by the <strong>International Laboratory Accreditation Cooperation (ILAC)<\/strong> through mutual recognition arrangements (<a href=\"https:\/\/nabl.qci.org.in\" target=\"_blank\" rel=\"noopener\">nabl.qci.org.in<\/a>).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>&#x26a0;&#xfe0f; Red Flag:<\/strong> If a supplier refuses to provide a CoA for a specific batch, or if the CoA lacks a laboratory reference number, this is a strong indicator that the product may not have undergone proper testing. Legitimate manufacturers make batch CoAs available upon request as a standard practice.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f3ed; NABL-Accredited Testing Laboratories in India<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">As of 2026, India has over <strong>1,400 NABL-accredited pharmaceutical testing laboratories<\/strong>, including both government facilities and private third-party labs. Key facilities include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Central Drugs Laboratory (CDL)<\/strong>, Kolkata \u2014 India&#8217;s national control laboratory and WHO-prequalified<\/li>\n<li><strong>Regional Drug Testing Laboratories (RDTLs)<\/strong> in Mumbai, Chennai, Hyderabad, Guwahati, and other cities<\/li>\n<li><strong>State Drug Control Laboratories<\/strong> under respective State FDAs<\/li>\n<li><strong>Private third-party labs<\/strong> such as SGS India, TUV Rheinland, Intertek, and numerous independent NABL-accredited facilities<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">In addition to batch release testing, CDSCO conducts <strong>random surveillance sampling<\/strong> of marketed drugs each year. Samples are drawn from pharmacies, distribution centres, and manufacturing facilities for independent testing at government labs. Under India&#8217;s &#8220;Jan Aushadhi&#8221; initiative, samples from Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) stores \u2014 which sell quality generics at affordable prices \u2014 are tested regularly to maintain public confidence.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f30d; How Indian Testing Standards Compare Globally<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Indian pharmacopoeial standards (<strong>IP<\/strong>) are closely harmonised with international standards. In most cases, the IP monograph for a drug substance or product uses the same or equivalent test methods and limits as the USP or BP. Key points of comparison:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Assay limits:<\/strong> Typically 95.0%-105.0% for finished products \u2014 consistent with USP and BP<\/li>\n<li><strong>Dissolution specifications:<\/strong> Q = 80% in 30-45 minutes for immediate-release products \u2014 same as international norms<\/li>\n<li><strong>Impurity limits:<\/strong> Follow ICH Q3A\/Q3B guidelines for identification and qualification thresholds<\/li>\n<li><strong>Microbial limits:<\/strong> Match USP <61>\/<62> and EP 2.6.12\/2.6.13 methods<\/li>\n<li><strong>Stability testing:<\/strong> Follows ICH Q1A (R2) guidelines \u2014 25\u00b0C\/60% RH for long-term, 40\u00b0C\/75% RH for accelerated<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">For products exported to regulated markets (US, EU, UK, Australia, Japan), Indian manufacturers must also meet the specific pharmacopoeial and GMP requirements of the destination country \u2014 and are inspected by the respective regulatory agencies (US FDA, MHRA, TGA, PMDA) for approval.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x2705; Practical Quality Checklist for Buyers<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">When evaluating an Indian generic medicine supplier, request and verify the following:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>\u2713 WHO-GMP Certificate:<\/strong> Issued by CDSCO or State FDA \u2014 verify validity on the CDSCO portal<\/li>\n<li><strong>\u2713 Batch-specific Certificate of Analysis (CoA):<\/strong> Must be from a NABL-accredited laboratory<\/li>\n<li><strong>\u2713 Stability study data:<\/strong> Should include both long-term (25\u00b0C) and accelerated (40\u00b0C) conditions<\/li>\n<li><strong>\u2713 Manufacturing licence:<\/strong> Issued by the State FDA under the Drugs and Cosmetics Act, 1940<\/li>\n<li><strong>\u2713 Drug Master File (DMF):<\/strong> If the product is exported to regulated markets<\/li>\n<li><strong>\u2713 Third-party audit reports:<\/strong> Many reputable manufacturers welcome buyer audits or share recent inspection findings from regulators<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">For a list of verified and reliable pharmaceutical distributors who adhere to these quality standards, refer to the <a href=\"https:\/\/indiamedicine.org\/?page_id=1454\">IMSDA&#8217;s verified member directory<\/a>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">For more information, contact IMSDA at contact@indiamedicine.org.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>One of the most common questions international buyers ask about Indian generic medicines is: &#8220;How do I know the quality is real?&#8221; The answer lies in the rigorous, multi-stage laboratory testing that every batch of medicine undergoes before it reaches the market. Understanding this testing framework can help buyers make informed decisions and evaluate suppliers [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[42,48,29,49],"class_list":["post-3627","post","type-post","status-publish","format-standard","hentry","category-knowledge","tag-cdsco","tag-generic-medicines","tag-india-pharmacy","tag-indian-pharma","entry"],"_links":{"self":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3627"}],"version-history":[{"count":0,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3627\/revisions"}],"wp:attachment":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}